Skip to content

MDG Concept: what changed

BE 0758.936.611NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€1,615
2024 · €2,411-€4,026
Equity
€19,709
2024 · €21,324-€1,615
Cash
€20,057
2024 · €21,486-€1,429
Balance sheet total
€20,422
2024 · €22,367-€1,946

Largest movements

2024 to 2025
Assets
  • Cash -€1,429

    down €1,429 (-6.7%), from €21,486 to €20,057

    mainly Net result for the year (-€1,615) and Tax, wage and social debts (-€469)

  • Receivables within one year -€516

    down €516 (-79.2%), from €651 to €135

    of which Other amounts receivable: -€413

Equity and liabilities
  • Profit (loss) carried forward -€1,615

    first reported in 2025, at -€1,615

  • Tax, wage and social debts -€469

    no longer reported in 2025; in 2024 it stood at €469

Income statement
  • Gross operating margin -€4,406

    down €4,406, from €3,033 to -€1,372

  • Taxes -€469

    no longer reported in 2025; in 2024 it stood at €469

  • Financial charges +€88

    up €88 (+226%), from €39 to €127

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €2,411
Gross operating margin -€4,406
Other operating charges -€2
Financial income +€1
Financial charges -€88
Taxes +€469
Result 2025 -€1,615
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1,429
Investment €0
Financing €0
Cash 2024 €21,486
Net result for the year -€1,615
Receivables within one year +€516
Trade debts +€138
Tax, wage and social debts -€469
Cash 2025 €20,057
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €22,367 €20,422 -€1,946 -8.7%
Current assets 29/58 €22,367 €20,422 -€1,946 -8.7%
Amounts receivable within one year 40/41 €651 €135 -€516 -79.2%
Trade receivables 40 €103 - -€103
Other amounts receivable 41 €548 €135 -€413 -75.3%
Cash at bank and in hand 54/58 €21,486 €20,057 -€1,429 -6.7%
Deferred charges and accrued income 490/1 €230 €230 = 0.0%
Total equity and liabilities 10/49 €22,367 €20,422 -€1,946 -8.7%
Equity 10/15 €21,324 €19,709 -€1,615 -7.6%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €18,324 €18,324 = 0.0%
Distributable reserves 133 €18,324 €18,324 = 0.0%
Profit (loss) carried forward 14 - -€1,615 -€1,615
Amounts payable 17/49 €1,044 €713 -€331 -31.7%
Amounts payable within one year 42/48 €1,044 €713 -€331 -31.7%
Trade debts 44 €575 €713 +€138 +24.0%
Suppliers 440/4 €575 €713 +€138 +24.0%
Taxes, remuneration and social security 45 €469 - -€469
Taxes 450/3 €469 - -€469
Other operating charges 640/8 €118 €120 +€2 +1.7%
Gross operating margin 9900 €3,033 -€1,372 -€4,406
Operating profit (loss) 9901 €2,915 -€1,492 -€4,408
Financial income 75/76B €4 €5 +€1 +21.5%
Recurring financial income 75 €4 €5 +€1 +21.5%
Financial charges 65/66B €39 €127 +€88 +226%
Recurring financial charges 65 €39 €127 +€88 +226%
Profit (loss) for the period before taxes 9903 €2,880 -€1,615 -€4,495
Income taxes 67/77 €469 - -€469
Profit (loss) for the period 9904 €2,411 -€1,615 -€4,026
Profit (loss) for the period to be appropriated 9905 €2,411 -€1,615 -€4,026

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€19,709 to €19,709

Midpoint €19,709 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €19,709
Indication €19,709

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€19,709
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€19,709

Capitalised earnings

net result for the year (9904)
2025
-€1,615
2024
€2,411
2023
-€1,475
2022
€280
2021
€17,107
Average result
-€226
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.